Could a Pre-Surgery drug boost nasal polyp treatment?
NCT ID NCT07616609
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether taking the drug stapokibart for 4 weeks before sinus surgery helps adults with chronic nasal polyps more than surgery alone. About 48 participants will receive either the drug or a placebo before their operation and be followed for nearly a year. The goal is to see if the combination reduces polyps and symptoms better than surgery alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, 100730, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection shrink nasal polyps and restore easy breathing?
- New study tests tezepelumab for chronic sinusitis sufferers
- 88% of patients with asthma and nasal polyps achieve dual remission on dupilumab
- Scientists probe the root cause of smell loss in chronic sinusitis
- Could a simple mucus test transform nasal polyp treatment?
- New drug BBT002 aims to ease sinus and asthma symptoms